Davidson Kempner Capital Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $35M 25M 1.41
2025-06-30 $23M 20M 1.14
2025-03-31 $32M 25M 1.28